» Articles » PMID: 26204212

Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice

Overview
Journal Clin Nucl Med
Specialty Nuclear Medicine
Date 2015 Jul 24
PMID 26204212
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Glioma grading is necessary for prognostic evaluation and optimal treatment decisions. The aims of this study were to establish whether a correlation between F-FDOPA uptake with tumor grade was observed and to determine which of the SUV-derived indices was the best correlated.

Patients And Methods: Thirty-one patients were retrospectively included (mean [SD] age, 36.8 [12.1] years) including 21 proven low-grade tumors due to histology, imaging, and clinical follow-up and 10 histologically proven high-grade tumors. Static PET acquisitions were postreconstructed between the 10th and 30th minute after injection of F-FDOPA. Regions of interest of 20 mm were applied to tumors, and isocontoured volumes were defined at levels of 50% and 80% of the peak intensity voxel. Background was quantified with 30-mm-diameter regions of interest on contralateral striatum and centrum semioval. Tumoral uptake was evaluated with the following SUV-derived indices: SUVmax, SUVmean, SUVmax, and SUVmean of isocontoured volume, tumor/striatum ratio (T/S), and tumor/normal brain ratio (T/N).

Results: All the SUV-derived indices tested were significantly correlated with tumor grade, considering low-grade and high-grade groups (P < 0.05), except for the SUVmean 50%. The 2 best-correlated indices were SUVmean T/N and SUVmean T/S, with correlation coefficients of 0.561 and 0.522, respectively. Receiver operating characteristic analysis defined optimal thresholds of 1.33 and 1 for sensitivity and specificity of 71% and 100% and 67% and 100%, respectively.

Conclusions: F-FDOPA PET SUV-derived indices are routinely available information that enables accurate discrimination of low-grade and high-grade gliomas. The best-correlated indices were SUVmean T/N and SUVmean T/S with thresholds of 1.33 and 1.

Citing Articles

A New Tool for Extracting Static and Dynamic Parameters from [F]F-DOPA PET/CT in Pediatric Gliomas.

Mureddu M, Funck T, Morana G, Rossi A, Ramaglia A, Milanaccio C J Clin Med. 2024; 13(20).

PMID: 39458202 PMC: 11508825. DOI: 10.3390/jcm13206252.


The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.

Zinsz A, Pouget C, Rech F, Taillandier L, Blonski M, Amlal S Eur J Nucl Med Mol Imaging. 2024; 51(9):2672-2683.

PMID: 38637354 DOI: 10.1007/s00259-024-06720-y.


Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer.

Jannusch K, Bittner A, Bruckmann N, Morawitz J, Stieglitz C, Dietzel F Cancers (Basel). 2023; 15(6).

PMID: 36980537 PMC: 10046153. DOI: 10.3390/cancers15061651.


Tracers progress for positron emission tomography imaging of glial-related disease.

Jia H, Xie T J Biomed Res. 2022; 36(5):321-335.

PMID: 36131689 PMC: 9548440. DOI: 10.7555/JBR.36.20220017.


What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review.

Zhang-Yin J, Girard A, Bertaux M Cancers (Basel). 2022; 14(4).

PMID: 35205625 PMC: 8870476. DOI: 10.3390/cancers14040879.